Article co-authored by Lisa Lacasse urges equal access to clinical trials.
The American Cancer Society Cancer Action Network (ACS CAN) is featured in the Urban One 2021 Engaging Black America Special Supplement issued today.
Published by the largest media company aimed at reaching the reaching the Black community, the annual publication focuses on issues impacting Black Americans. It is delivered to members of Congress and features editorial content by lawmakers and sponsor organizations on issues such as health care and education. In addition, the publication is also featured across Urban One media network websites.
In this year’s supplement, ACS CAN President Lisa Lacasse coauthored editorial content with Dr. Robert Carson, CEO of the National Comprehensive Cancer Network (NCCN), and Dr. Gary Puckrein, president and CEO of the National Minority Quality Forum (NMQF), focused on the issue of increasing diversity in cancer clinical trials, especially among Black patients.
The editorial discusses this health equity topic and how it impacts cancer disparities, and calls on lawmakers to pass legislation that would help to offset non-medical costs for patients associated with participating in a clinical trial. Increasing diversity in clinical trials is a priority for ACS CAN, which is partnering with NCCN and NMFQ closely on this issue through the Elevating Cancer Equity project.
ACS CAN’s efforts to increase clinical trial accessibility for all individuals regardless of race, age, gender, sexual orientation, income level, or ZIP code are part of its broader health equity advocacy work. In addition, an ACS CAN advertisement about this important issue is featured on the back cover of the supplement.
For more information on ACS CAN’s health equity advocacy work, visit fightcancer.org.